Summary Coronavirus disease 2019 (COVID-19) exhibits variable symptom severity ranging
from asymptomatic to life-threatening, yet the relationship between severity and the humoral …

The protective effect of neutralizing antibodies in SARS-CoV-2 infected individuals is not yet
well defined. To address this issue, we have analyzed the kinetics of neutralizing antibody …

Understanding how antibody responses to SARS-CoV-2 evolve during infection may
provide important insight into therapeutic approaches and vaccination for COVID-19. Here …

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) caused outbreaks of
the pandemic starting from the end of 2019 and, despite ongoing vaccination campaigns …

Summary SARS-CoV-2, the virus responsible for COVID-19, is causing a devastating
worldwide pandemic, and there is a pressing need to understand the development …

Abstract Development of antibody protection during SARS-CoV-2 infection is a pressing
question for public health and for vaccine development. We developed highly sensitive …

Background The COVID-19 pandemic caused by SARS-CoV-2 coronavirus threatens global
public health. Currently, neutralizing antibodies (NAbs) versus this virus are expected to …

Limited knowledge exists on immune markers associated with disease severity or recovery
in patients with coronavirus disease 2019 (COVID-19). Here, we elucidated longitudinal …

Understanding antibody-based SARS-CoV-2 immunity is critical for overcoming the COVID-
19 pandemic and informing vaccination strategies. We evaluated SARS-CoV-2 antibody …

Understanding the properties and mechanisms by which antibodies provide protection is
essential to defining immunity. Although neutralizing antibodies have been proposed as a …